Ownership history in SHELL ASSET MANAGEMENT CO · 7 quarters on record
This page tracks every 13F SEC filing in which SHELL ASSET MANAGEMENT CO reported a position in VERVE THERAPEUTICS INC (VERV). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q2 | UNCHANGED | 5,806 | — | 0% | 0.00% | $65K | — |
| 2025 Q1 | REDUCED | 5,806 | -229 | -3.8% | 0.00% | $27K | — |
| 2024 Q4 | UNCHANGED | 6,035 | — | 0% | 0.00% | $34K | — |
| 2024 Q3 | ADDED | 6,035 | +266 | +4.6% | 0.00% | $29K | — |
| 2024 Q2 | REDUCED | 5,769 | -353 | -5.8% | 0.00% | $28K | — |
| 2024 Q1 | REDUCED | 6,122 | -294 | -4.6% | 0.00% | $81K | — |
| 2023 Q4 | INITIATED | 6,416 | — | — | 0.00% | $89K | — |
As of 2025 Q3 — sorted by position size